glp 1 through row Ro Launches Wegovy® Pill Integration with Novo Nordisk GLP-1 therapies: a new frontier

10.1016/j.neulet.2005.10.056 186 KondoriN

**In a consumer study of 109 women after 28 days

GLP-1 receptor agonists work by mimicking the action of endogenous GLP-1, a hormone that stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, slows gastric emptying, and promotes satiety through central nervous system pathways

Additionally, those with type 1 diabetes who use SGLT2 inhibitors run the risk of developing diabetic ketoacidosis (DKA)

massiliensis and E

In patients using Ozempic, symptoms of nAMD were rapid-onset, occurring after the start of treatment, and were sometimes misdiagnosed as typical diabetic vision changes